Last update 06 Jun 2025

Afimkibart

Overview

Basic Info

Drug Type
Monoclonal antibody
Synonyms
PF 6480605, PF-06480605, PF-6480605
+ [3]
Target
Action
inhibitors
Mechanism
VEGI inhibitors(Tumor necrosis factor superfamily member 15 inhibitors)
Inactive Indication-
Originator Organization
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Crohn DiseasePhase 3
United States
12 May 2025
Crohn DiseasePhase 3
China
12 May 2025
Crohn DiseasePhase 3
Australia
12 May 2025
Crohn DiseasePhase 3
Canada
12 May 2025
Crohn DiseasePhase 3
Colombia
12 May 2025
Crohn DiseasePhase 3
France
12 May 2025
Crohn DiseasePhase 3
Poland
12 May 2025
Crohn DiseasePhase 3
United Kingdom
12 May 2025
Crohn's disease, active moderatePhase 3
Canada
26 Mar 2025
Crohn's disease, active moderatePhase 3
Serbia
26 Mar 2025
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
12
(PF-06480605 450mg)
kvihhmveac(rnaeqmzfqr) = kgdllkuszi kyacrliude (ocnirrvyni, 26)
-
21 Mar 2024
placebo
(Placebo)
exndkoopgd = rwenfzwmih ijhefkhzfo (gjyehkuhuq, fdvgtyvuqe - fjftcqegdm)
Phase 2
-
wrbbqwabfo(zptatqotfw) = pmsybzxnfh hxxdlmnpvo (iechknqhmt )
Positive
22 Jun 2023
Phase 2
45
yyfvpzwtfs(lxnkuhckup) = mpltvfuofk ggptseygaw (ahhcyckznz )
Positive
28 Oct 2020
Phase 2
50
fmqfhcfnsk = uxeutiphkr polnakuwaj (emdduyesiy, lmpvqsdsae - bdmcarkrwp)
-
19 Jun 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free